HORN HOWARD (Chief Financial Officer) sold 4.1% of their position (4.68K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $116.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001193125-26-204402
Officer· Chief Financial Officer
Since Mar 2026
-4.68K
Net shares
Net seller
$116.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.68K
Price / share
$24.90
Trade value
$116.61K
% of position
4.1%
5/1/2026
115.03K→110.34K
Total
Net shares
−4.68K
Net value
-$116.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −4.68K | $24.90 | $116.61K | 4.1% | 115.03K | 110.34K |
| Total | −4.68K | -$116.61K | ||||||
Derivative Transactions0
No derivative transactions reported